Processing your payment...
Please do not close your browser.

Closed System Drug Transfer Device (CSTD) Market - Global Growth, Trends and Forecast (2022 - 2027) By Types, By Application, By Regions and By Key Players: B. Braun Holding GmbH & Co. KG, Baxter International, Becton, Dickinson and Company

20 Jul, 2022 | 134 Pages
Shares
facebook sharing button
linkedin sharing button
twitter sharing button
sharethis sharing button

The global Closed System Drug Transfer Device (CSTD) market reached a value of US$ 835.7 Million in 2021. Looking ahead, the market is expected to reach $ 3,308.4 Million by 2027, growing at a CAGR of 16.1% between 2022 and 2027.



Closed System Drug Transfer Device (CSTD) Market Overview



CSTDs are frequently used in medical equipment to keep a fluid channel sterile. To maintain the purity of the solution to be injected into a patient, they prevent the unchecked entry and exit of contaminants and medications. Contaminants may still be found despite the use of CSTDs due to inappropriate handling or poor product design, even though it should provide complete safety to healthcare personnel while handling dangerous medications.



The market's expansion may be attributed mostly to increased occupational safety awareness among healthcare employees, as well as the requirement to use products that aid to reduce surface contamination. Additionally, it is projected that the market would rise as a result of the rapid use of automated drug compounding robots in healthcare settings and the rising product development in the field of CSTDs. Additionally, the rising incidence of cancer cases around the world and the demand for chemotherapies are anticipated to fuel market expansion in the upcoming years. According to the WHO, there will be close to 10 million cancer-related deaths worldwide in 2020. Moreover, breast cancer was known to be the most common in terms of new cases of cancer, registering 2.26 million cases in the same year.



The growing need for monitoring compliance for safe pharmaceutical handling is propelling the closed system transfer device market forward. Drugs used to treat antineoplastic conditions can prolong or improve a patient's life, but they can also be harmful to the health of medical personnel. This could happen if there is surface contamination or if medications escape during preparation, administration, or patient delivery. All quantities of chemotherapy medications are prepared by pharmacy staff at the oncology center under the direction of a licensed pharmacist.



Industry News and Updates:



December 2, 2021: B. Braun Medical Launches Next Generation OnGuard 2 CSTD--

B. Braun Medical Inc., a leading provider of closed system transfer devices (CSTD), announced today that the OnGuard 2 CSTD is now available in the United States. OnGuard 2 incorporates all of the current advantages of OnGuard, while offering upgraded materials and enhanced features to improve its usability. The National Institute for Occupational Safety and Health (NIOSH) recognizes air-cleaning technology for closed system drug transfer devices to prevent the escape of hazardous drugs into the environment. 



JUNE 11, 2021: FDA Grants ONB Clearance to Yukon Medical for Arisure Closed System Transfer Device --

Yukon Medical, a medical device firm dedicated to innovation in medication preparation and administration, announced today that the U.S. Food and Drug Administration (FDA) has cleared the Arisure Closed System Transfer Device (CSTD) under the ONB Product Classification. The Arisure Closed System Transfer Device (CSTD) is an airtight and leakproof system that minimizes exposure of individuals, healthcare personnel, and the environment to hazardous drugs. Arisure CSTD mechanically prohibits the release of drugs in vapor, aerosol, or liquid form during preparation and administration. It also prevents the introduction of microbial and airborne contaminants into the drug or fluid path for up to seven days and ten activations.



What are the major Applications, Types and Regions for Closed System Drug Transfer Device (CSTD) Market?



Market is segmented based on the type, applications, companies and regions.



By Type, it is segmented into




  • Closed Vial Access Devices

  • Closed Syringe Safety Devices

  • Closed Bag/Line Access Devices



By Application, it is segmented into




  • Hospital

  • Clinic



Closed System Drug Transfer Device (CSTD) Market Segments Analysis:




  • The segment of closed syringe safety holds a comparatively larger share in global market, which accounts for about 35%.

  • The hospital holds an important share in terms of applications, and accounts for 92% of the market share.



Closed System Drug Transfer Device (CSTD) Market Regional Analysis



The market for closed-system medication transfer devices is dominated by the North American region. In terms of market share, America rules in this area. The reason for this is that its healthcare system is sophisticated and complex. Some of the greatest hospitals in the world are located there. The cost of healthcare, both public and private, is likewise very high in this country. Additionally, it contains some of the top medical and healthcare research centres in the world.



The Asia-Pacific region's growth rate would be slower, owing to the lack of regulation in the closed-system drug transfer device industry. Furthermore, despite the fact that healthcare spending in most Asian countries has increased, the governments of such countries don't prioritise it.




  • North America


    • US

    • Canada



  • Europe

    • Germany

    • France

    • UK

    • Italy

    • Spain

    • Rest of Europe



  • Asia-Pacific

    • China

    • Japan

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific



  • Rest of the World

    • Middle East & Africa

    • Latin America





The Closed System Drug Transfer Device (CSTD) Market describes the factors driving the global growth opportunities in upcoming years and highlights market channels. In addition, the report analyzes market size and share, trends, by geographic region, end-use type and segment. It focuses extensively on revealing a detailed regional analysis. The Global Closed System Drug Transfer Device (CSTD) Market report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.



What is our Closed System Drug Transfer Device (CSTD) Market report scope?























































Report Attributes



Report Details



Forecast Period 2022 to 2027 CAGR



CAGR of 16.1% over the forecast period (2022-2027)



By Type




  • Closed Vial Access Devices

  • Closed Syringe Safety Devices

  • Closed Bag/Line Access Devices



By Application




  • Hospital

  • Clinic



By Companies



B. Braun Holding GmbH & Co. KG, Baxter International, Becton, Dickinson and Company, Caragen Ltd, Corvida Medical, Equashield, FIMI Opportunity Funds (Simplivia Healthcare), ICU Medical, JCB Co Ltd. (JMS Co Ltd.), Yukon Medical, Teva Medical Ltd, JMS, CODAN Medizinische Geräte, VICTUS



Regions Covered




  • North America

  • Europe

  • Asia-Pacific

  • Rest of the World



Countries Covered




  • US

  • Canada

  • Germany

  • France

  • UK

  • Italy

  • Spain

  • Rest of Europe

  • China

  • Japan

  • India

  • Australia

  • South Korea

  • Rest of Asia-Pacific

  • Middle East & Africa

  • Latin America



Base Year



2022



Historical Year



2017 to 2021



Forecast Year



2022 to 2027



Number of Pages



134



Customization Available



Yes, the report can be customized as per your needs




 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



Key Takeaways from this Closed System Drug Transfer Device (CSTD) Market Report




  • Evaluate Closed System Drug Transfer Device (CSTD) market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level - for product types, end use applications and by different industry verticals.

  • Understand the different dynamics influencing the market - growth driving factors, specific challenges and hidden opportunities.

  • Get in-depth insights on your competitor performance – revenue, shares, business strategies, financial benchmarking, product benchmarking, SWOT analysis and more.

  • Analyze the sales and distribution channels across geographies to enhance top-line revenues.

  • Understand the demanding supply chain with a deep dive on the value augmentation at each, in order to optimize value and bring efficiencies in your processes.

  • Get a quick outlook on the Closed System Drug Transfer Device (CSTD) market entropy - M&A's, deals, partnerships, product launches of all key players for the past 4 years.

  • Evaluate the import-export statistics, supply-demand and competitive landscape for more than top 20 countries globally for the market.



Frequently Asked Questions



What is the growth rate of Closed System Drug Transfer Device (CSTD) Market?



The Closed System Drug Transfer Device (CSTD) Market is growing at a CAGR of 16.1% over the next 5 years.



Who are the key players in Closed System Drug Transfer Device (CSTD) Market?



B. Braun Holding GmbH & Co. KG, Baxter International, Becton, Dickinson and Company, Caragen Ltd, Corvida Medical, Equashield, FIMI Opportunity Funds (Simplivia Healthcare), ICU Medical, JCB Co Ltd. (JMS Co Ltd.), Yukon Medical, Teva Medical Ltd, JMS, CODAN Medizinische Geräte, VICTUS



What are the significant types of Closed System Drug Transfer Device (CSTD) Market?



Closed Vial Access Devices, Closed Syringe Safety Devices, Closed Bag/Line Access Devices



What are the major end-use applications of Closed System Drug Transfer Device (CSTD) Market?



Hospital, Clinic



All our reports are custom made to your company needs to a certain extent, we do provide 5 free consulting hours along with purchase of each report, and this will allow you to request any additional data to customize the report as your needs.


  1. INTRODUCTION

    1. MARKET DEFINITION

    2. MARKET DYNAMICS

    3. MARKET SEGMENTATION

    4. REPORT TIMELINES

    5. KEY STAKEHOLDERS



  2. RESEARCH METHODOLOGY

    1. DATA MINING

      1. SECONDARY RESEARCH

      2. PRIMARY RESEARCH

      3. SUBJECT MATTER EXPERT ADVICE



    2. QUALITY CHECK

    3. FINAL REVIEW

      1. DATA TRIANGULATION

      2. BOTTOM-UP APPROACH

      3. TOP-DOWN APPROACH



    4. RESEARCH FLOW



  3. EXECUTIVE SUMMARY

    1. INTRODUCTION

    2. GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET BY TYPE

    3. GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET BY APPLICTAION



  4. MARKET DYNAMICS

    1. DRIVERS

      1. INCREASING DEMAND FOR CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD)



    2. RESTRAINTS

      1. STRINGENT ENVIRONMENTAL REGULATIONS

      2. HIGH COST ON MATERIALS



    3. OPPORTUNITIES

      1. CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) GROWTH

      2. APPLICATION OF CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD)



    4. IMPACT OF COVID 19



  5. GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE

    1. INTRODUCTION

    2. CLOSED VIAL ACCESS DEVICES

    3. CLOSED SYRINGE SAFETY DEVICES

    4. CLOSED BAG/LINE ACCESS DEVICES



  6. GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY APPLICATION

    1. INTRODUCTION

    2. CLOSED VIAL ACCESS DEVICES

    3. CLOSED SYRINGE SAFETY DEVICES

    4. CLOSED BAG/LINE ACCESS DEVICES



  7. GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY REGION

    1. NORTH AMERICA

      1. US

      2. CANADA

      3. MEXICO



    2. EUROPE

      1. GERMANY

      2. FRANCE

      3. UK

      4. ITALY

      5. RUSSIA

      6. REST OF EUROPE



    3. APAC

      1. CHINA

      2. SOUTH KOREA

      3. JAPAN

      4. INDIA

      5. AUSTRALIA

      6. ASEAN

      7. REST OF APAC



    4. MIDDLE EAST & AFRICA

      1. SAUDI ARABIA

      2. UAE

      3. SOUTH AFRICA

      4. TURKEY

      5. REST OF MEA



    5. SOUTH AMERICA

      1. BRAZIL

      2. REST OF MEA

      3. ARGENTINA

      4. REST OF SOUTH AMERICA





  8. COMPETITIVE LANDSCAPE

    1. MERGERS, ACQUISITIONS, JOINT VENTURES, COLLABORATIONS,

    2. AND AGREEMENTS

      1. KEY DEVELOPMENT



    3. MARKET SHARE (%) **/RANKING ANALYSIS

    4. STRATEGIES ADOPTED BY LEADING PLAYERS



  9. COMPANY PROFILES

    1. BUSINESS OVERVIEW

    2. COMPANY SNAPSHOT

    3. PRODUCT BENCHMARKING

    4. STRATEGIC INITIATIVES

      1. BD MEDICAL, INC

      2. EQUASHIELD

      3. ICU MEDICAL

      4. TEVA MEDICAL LTD

      5. CORVIDA MEDICAL

      6. B. BRAUN

      7. VICTUS

      8. CARAGEN

      9. BAXTER INTERNATIONAL

      10. FIMI OPPORTUNITY FUNDS (SIMPLIVIA HEALTHCARE)

      11. JCB CO LTD. (JMS CO LTD.)

      12. YUKON MEDICAL





SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

Please Choose License Type

  • Single User License
    $2500
  • Site License
    $3000
  • Global License
    $5000

How can we help you?

Reach us with your research requirements and we shall provide the optimum solution to suit your needs.

Curioust about Multiple Reports?

Discounts available for multiple report purchases.

Contact Us

Our Clients

  • Merck
  • IBM
  • Dow
  • Henkel
  • AirBus
  • Cummins
  • Intel
  • Sony
  • 9
  • 3M